Amneal Pharmaceuticals (AMRX) Enterprise Value (2018 - 2026)
Amneal Pharmaceuticals' Enterprise Value was $6.97 billion in Q3 2026, up 131.3% from $3.01 billion a year earlier and up 27.1% from the prior quarter.
Amneal Pharmaceuticals (AMRX) Enterprise Value (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Amneal Pharmaceuticals' Enterprise Value was $6.36 billion through Sep 30, 2026, up 129.5% year-over-year; for FY2025, it was $3.76 billion, up 56.0% from FY2024.
- Enterprise Value has now increased for three consecutive years, with a five-year compound annual growth rate of 29.3% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $2.41 billion in FY2024 (+33.1%), $1.81 billion in FY2023 (+200.1%), $603.17 million in FY2022 (-50.3%) and $1.21 billion in FY2021 (+16.6%).
- The Q3 2026 figure marks the highest quarterly Enterprise Value in data going back to Q2 2018.
- Compared with a year earlier, Enterprise Value has increased for 13 straight quarters, with growth averaging 58.7% over the last eight quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q1 2024 (growth of 508.6%); the worst was Q1 2023 (a decline of 71.2%).
- Per Business Quant data, AMRX's Enterprise Value in the three quarters before Q3 2026 was $5.48 billion (Q2 2026), $3.85 billion (Q1 2026) and $3.76 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,304.70 Bn | 1,278.32 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 690.68 Bn | 610.54 Bn | 17.30 Bn |
| 3 | AbbVie | 528.28 Bn | 496.29 Bn | 13.12 Bn |
| 4 | Merck | 365.24 Bn | 328.18 Bn | 13.19 Bn |
| 5 | Novartis Ag | 314.66 Bn | 287.90 Bn | - |
| 6 | Astrazeneca | 288.53 Bn | 262.05 Bn | 13.26 Bn |
| 7 | Amgen | 253.39 Bn | 205.04 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.48 Bn | 185.59 Bn | 6.73 Bn |
| 9 | Pfizer | 165.27 Bn | 112.63 Bn | 12.56 Bn |
| 10 | Amneal Pharmaceuticals | 7.17 Bn | 6.41 Bn | 334.12 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.97 Bn |
| Jun 30, 2026 | 5.48 Bn |
| Mar 31, 2026 | 3.85 Bn |
| Dec 31, 2025 | 3.76 Bn |
| Sep 30, 2025 | 3.01 Bn |
| Jun 30, 2025 | 2.54 Bn |
| Mar 31, 2025 | 2.64 Bn |
| Dec 31, 2024 | 2.41 Bn |
| Sep 30, 2024 | 2.56 Bn |
| Jun 30, 2024 | 1.98 Bn |
| Mar 31, 2024 | 1.87 Bn |
| Dec 31, 2023 | 1.81 Bn |
| Sep 30, 2023 | 1.24 Bn |
| Jun 30, 2023 | 872.39 Mn |
| Mar 31, 2023 | 307.41 Mn |
| Dec 31, 2022 | 603.17 Mn |
| Sep 30, 2022 | 548.20 Mn |
| Jun 30, 2022 | 890.44 Mn |
| Mar 31, 2022 | 1.07 Bn |
| Dec 31, 2021 | 1.21 Bn |
Amneal Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=AMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();